One year results of intravitreal ranibizumab monotherapy for retinal angiomatous proliferation: a comparative analysis based on disease stages

BACKGROUND: Retinal angiomatous proliferation (RAP) has been known as a variant of exudative age-related macular degeneration (AMD) with a unfavorable prognosis. To evaluate the effect of ranibizumab administered initially as three loading doses for patients with various stages of RAP. METHODS: A re...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Young Gun, Roh, Young-Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4685625/
https://www.ncbi.nlm.nih.gov/pubmed/26691185
http://dx.doi.org/10.1186/s12886-015-0172-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4685625/
https://www.ncbi.nlm.nih.gov/pubmed/26691185
http://dx.doi.org/10.1186/s12886-015-0172-2

Ejemplares similares